Hyperfine (NASDAQ:HYPR), the medical technology firm behind the first portable, AI-powered brain imaging system, reported a dramatic surge in fourth-quarter revenue, signaling a potential turning point for its bedside MRI technology.
The Guilford, Connecticut-based company expects fourth-quarter revenue of approximately $5.3 million, a 127% increase over the same period last year.
The preliminary results, released Monday, also show a 54% sequential jump from the third quarter of 2025, suggesting accelerated commercial momentum for its flagship Swoop® system.
The quarter’s performance helped pull full-year revenue to approximately $13.5 million, a 5% increase over 2024.
While the annual growth appears modest compared to the year-end sprint, the figures indicate a significant back-half recovery for the company as it scales its footprint in hospitals and emergency departments.
Management also highlighted improved capital efficiency. Preliminary net cash burn for the fourth quarter fell 30% year-over-year to $5.7 million.
For the full year, Hyperfine reduced its cash burn by 22% to $29.9 million, excluding financing activities.
The company ended 2025 with approximately $35.1 million in cash and cash equivalents.